Brainsway

🇮🇱Israel

Country: 🇮🇱Israel

Ownership: -

Employees: 106

Market Cap: -

Website

Introduction: Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Clinical Trials

New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)

Not Applicable

Active, not recruiting

Conditions: Major Depressive Disorder

Interventions: Device: Brainsway Deep TMS System

First Posted Date: 2024-04-10

Last Posted Date: 2025-04-08

Lead Sponsor: Brainsway

Target Recruit Count: 104

Registration Number: NCT06357832

Locations: 🇺🇸
Novus Neurology, Tuscaloosa, Alabama, United States
🇺🇸
Inland Psychiatric Medical Group, Inc., Redlands, California, United States
🇺🇸
DTMS Center LLC, Palm Beach, Florida, United States

and more 6 locations

Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects

Not Applicable

Conditions: Obsessive-Compulsive Disorder

Interventions: Device: BrainsWay Deep TMS HAC/H7-Coil
Device: BrainsWay Deep TMS Sham Coil

First Posted Date: 2022-06-03

Last Posted Date: 2022-07-20

Lead Sponsor: Brainsway

Target Recruit Count: 124

Registration Number: NCT05404360

Brainsway DTMS for Treatment of MDD Using iTBS

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Device: Brainsway DTMS with intermittent Theta Burst Stimulation (iTBS)
Device: Brainsway DTMS with High Frequency (HF) Stimulation

First Posted Date: 2020-12-22

Last Posted Date: 2020-12-23

Lead Sponsor: Brainsway

Target Recruit Count: 177

Registration Number: NCT04679753

Locations: 🇨🇦
SynapseTMS, Yorkton, Saskatchewan, Canada

Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

Conditions: Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment

First Posted Date: 2020-07-02

Last Posted Date: 2020-07-09

Lead Sponsor: Brainsway

Target Recruit Count: 540

Registration Number: NCT04455646

Locations: 🇺🇸
Kadima Neuropsychiatry, San Diego, California, United States
🇺🇸
Advanced Mental Health Care Inc. - Juno Beach, Juno Beach, Florida, United States
🇺🇸
Advanced Mental Health Care Inc. - Palm Beach, Palm Beach, Florida, United States

and more 19 locations

Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

Not Applicable

Conditions: Major Depressive Disorder (MDD)

Interventions: Device: H7-Coil
Device: H1-Coil

First Posted Date: 2017-01-06

Last Posted Date: 2020-07-15

Lead Sponsor: Brainsway

Target Recruit Count: 106

Registration Number: NCT03012724

Locations: 🇨🇦
Center for Addiction & Mental Health (CAMH), Toronto, Ontario, Canada
🇺🇸
CalNeuro Research Group, Los Angeles, California, United States
🇺🇸
Kadima Neuropsychiatry, La Jolla, California, United States

and more 6 locations

A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)

Not Applicable

Terminated

Conditions: Post-Traumatic Stress Disorder

Interventions: Device: Sham Treatment
Device: Deep TMS System

First Posted Date: 2015-06-24

Last Posted Date: 2020-05-14

Lead Sponsor: Brainsway

Target Recruit Count: 203

Registration Number: NCT02479906

Locations: 🇨🇦
Center for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada
🇺🇸
Yellowbrick Foundation, Evanston, Illinois, United States
🇺🇸
University of California - San Diego Medical Center, San Diego, California, United States

and more 12 locations

Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual

Not Applicable

Withdrawn

Conditions: Depression

Interventions: Device: dTMS

First Posted Date: 2014-10-09

Last Posted Date: 2021-02-08

Lead Sponsor: Brainsway

Registration Number: NCT02260765

Locations: 🇺🇸
Healthcare Partners, Los Angeles, California, United States

An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

Not Applicable

Completed

Conditions: Obsessive Compulsive Disorder

Interventions: Device: Sham Treatment
Device: Active DTMS Treatment

First Posted Date: 2014-09-03

Last Posted Date: 2020-07-15

Lead Sponsor: Brainsway

Target Recruit Count: 100

Registration Number: NCT02229903

Locations: 🇺🇸
University of California (UCLA), Los Angeles, California, United States
🇺🇸
University of California, San Diego, California, United States
🇺🇸
Neuropharmacology Services, New York, New York, United States

and more 9 locations

Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

Phase 3

Completed

Conditions: Smoking Cessation

Interventions: Device: Active dTMS Treatment
Device: Sham Treatment

First Posted Date: 2014-04-29

Last Posted Date: 2020-12-04

Lead Sponsor: Brainsway

Target Recruit Count: 224

Registration Number: NCT02126124

Locations: 🇺🇸
Senior Adults Specialty Research, Austin, Texas, United States
🇺🇸
Advanced Mental Health Care Inc. - Juno Beach, Juno Beach, Florida, United States
🇺🇸
Mount Sinai Hospital, New York, New York, United States

and more 14 locations

Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus.

Phase 2

Withdrawn

Conditions: Tinnitus

Interventions: Device: Deep Transcranial Magnetic Stimulation

First Posted Date: 2014-02-04

Last Posted Date: 2018-01-25

Lead Sponsor: Brainsway

Registration Number: NCT02053961

Locations: 🇮🇱
Wolfson Hospital, Holon, Israel

Home Terms & Conditions Privacy Policy